4//SEC Filing
Newman Michael James 4
Accession 0001493152-23-002019
CIK 0001857044other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:05 PM ET
Size
5.5 KB
Accession
0001493152-23-002019
Insider Transaction Report
Form 4
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-01-18+43,250→ 43,250 totalExercise: $1.61Exp: 2033-01-18→ Common Stock (43,250 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001876315
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:05 PM ET
- Size
- 5.5 KB